A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16

Valerio Carelli, Simone Schimpf, Nico Fuhrmann, Maria Lucia Valentino, Claudia Zanna, Luisa Iommarini, Monika Papke, Simone Schaich, Sabine Tippmann, Britta Baumann, Piero Barboni, Lora Longanesi, Michela Rugolo, Anna Ghelli, Marcel V. Alavi, Richard J. Youle, Laura Bucchi, Rosanna Carroccia, Maria Pia Giannoccaro, Caterina TononRaffaele Lodi, Giovanna Cenacchi, Pasquale Montagna, Rocco Liguori, Bernd Wissinger

Research output: Contribution to journalArticle

Abstract

Dominant optic atrophy (DOA) is genetically heterogeneous and pathogenic mutations have been identified in the OPA1 and OPA3 genes, both encoding for mitochondrial proteins. We characterized clinical and laboratory features in a large OPA1-negative family with complicated DOA. Search for mitochondrial dysfunction was performed by studying muscle biopsies, fibroblasts, platelets and magnetic resonance (MR) spectroscopy. Genetic investigations included mitochondrial DNA (mtDNA) analysis, linkage analysis, copy number variation (CNV) analysis and candidate gene screening. Optic neuropathy was undistinguishable from that in OPA1-DOA and frequently associated with late-onset sensorineural hearing loss, increases of central conduction times at somato-sensory evoked potentials and various cardiac abnormalities. Serum lactic acid after exercise, platelet respiratory complex activities, adenosine triphosphate (ATP) content in fibroblasts and muscle phosphorus MR spectroscopy all failed to reveal a mitochondrial dysfunction. However, muscle biopsies and their mtDNA analysis showed increased mitochondrial biogenesis. Furthermore, patient's fibroblasts grown in the galactose medium were unable to increase ATP content compared with controls, and exhibited abnormally high rate of fusion activity. Genome-wide linkage revealed a locus on chromosome 16q21-q22 with a maximum two-point LOD score of 8.84 for the marker D16S752 and a non-recombinant interval of ~6.96 cM. Genomic screening of 45 genes in this interval including several likely candidate genes (CALB2, CYB5B, TK2, DHODH, PLEKHG4) revealed no mutation. Moreover, we excluded the presence of CNVs using array-based comparative genome hybridization. The identification of a new OPA locus (OPA8) in this pedigree demonstrates further genetic heterogeneity in DOA, and our results indicate that the pathogenesis may still involve mitochondria.

Original languageEnglish
Article numberddr071
Pages (from-to)1893-1905
Number of pages13
JournalHuman Molecular Genetics
Volume20
Issue number10
DOIs
Publication statusPublished - May 2011

Fingerprint

Autosomal Dominant Optic Atrophy
Chromosomes, Human, Pair 16
Fibroblasts
Mitochondrial DNA
Muscles
Magnetic Resonance Spectroscopy
Blood Platelets
Adenosine Triphosphate
Genes
Biopsy
Optic Nerve Diseases
Mutation
Comparative Genomic Hybridization
Genetic Heterogeneity
Sensorineural Hearing Loss
Mitochondrial Proteins
Genetic Association Studies
Organelle Biogenesis
Pedigree
Galactose

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology

Cite this

Carelli, V., Schimpf, S., Fuhrmann, N., Valentino, M. L., Zanna, C., Iommarini, L., ... Wissinger, B. (2011). A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16. Human Molecular Genetics, 20(10), 1893-1905. [ddr071]. https://doi.org/10.1093/hmg/ddr071

A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16. / Carelli, Valerio; Schimpf, Simone; Fuhrmann, Nico; Valentino, Maria Lucia; Zanna, Claudia; Iommarini, Luisa; Papke, Monika; Schaich, Simone; Tippmann, Sabine; Baumann, Britta; Barboni, Piero; Longanesi, Lora; Rugolo, Michela; Ghelli, Anna; Alavi, Marcel V.; Youle, Richard J.; Bucchi, Laura; Carroccia, Rosanna; Giannoccaro, Maria Pia; Tonon, Caterina; Lodi, Raffaele; Cenacchi, Giovanna; Montagna, Pasquale; Liguori, Rocco; Wissinger, Bernd.

In: Human Molecular Genetics, Vol. 20, No. 10, ddr071, 05.2011, p. 1893-1905.

Research output: Contribution to journalArticle

Carelli, V, Schimpf, S, Fuhrmann, N, Valentino, ML, Zanna, C, Iommarini, L, Papke, M, Schaich, S, Tippmann, S, Baumann, B, Barboni, P, Longanesi, L, Rugolo, M, Ghelli, A, Alavi, MV, Youle, RJ, Bucchi, L, Carroccia, R, Giannoccaro, MP, Tonon, C, Lodi, R, Cenacchi, G, Montagna, P, Liguori, R & Wissinger, B 2011, 'A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16', Human Molecular Genetics, vol. 20, no. 10, ddr071, pp. 1893-1905. https://doi.org/10.1093/hmg/ddr071
Carelli, Valerio ; Schimpf, Simone ; Fuhrmann, Nico ; Valentino, Maria Lucia ; Zanna, Claudia ; Iommarini, Luisa ; Papke, Monika ; Schaich, Simone ; Tippmann, Sabine ; Baumann, Britta ; Barboni, Piero ; Longanesi, Lora ; Rugolo, Michela ; Ghelli, Anna ; Alavi, Marcel V. ; Youle, Richard J. ; Bucchi, Laura ; Carroccia, Rosanna ; Giannoccaro, Maria Pia ; Tonon, Caterina ; Lodi, Raffaele ; Cenacchi, Giovanna ; Montagna, Pasquale ; Liguori, Rocco ; Wissinger, Bernd. / A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16. In: Human Molecular Genetics. 2011 ; Vol. 20, No. 10. pp. 1893-1905.
@article{1a69678260dc4e80a2b5facc1628c4d0,
title = "A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16",
abstract = "Dominant optic atrophy (DOA) is genetically heterogeneous and pathogenic mutations have been identified in the OPA1 and OPA3 genes, both encoding for mitochondrial proteins. We characterized clinical and laboratory features in a large OPA1-negative family with complicated DOA. Search for mitochondrial dysfunction was performed by studying muscle biopsies, fibroblasts, platelets and magnetic resonance (MR) spectroscopy. Genetic investigations included mitochondrial DNA (mtDNA) analysis, linkage analysis, copy number variation (CNV) analysis and candidate gene screening. Optic neuropathy was undistinguishable from that in OPA1-DOA and frequently associated with late-onset sensorineural hearing loss, increases of central conduction times at somato-sensory evoked potentials and various cardiac abnormalities. Serum lactic acid after exercise, platelet respiratory complex activities, adenosine triphosphate (ATP) content in fibroblasts and muscle phosphorus MR spectroscopy all failed to reveal a mitochondrial dysfunction. However, muscle biopsies and their mtDNA analysis showed increased mitochondrial biogenesis. Furthermore, patient's fibroblasts grown in the galactose medium were unable to increase ATP content compared with controls, and exhibited abnormally high rate of fusion activity. Genome-wide linkage revealed a locus on chromosome 16q21-q22 with a maximum two-point LOD score of 8.84 for the marker D16S752 and a non-recombinant interval of ~6.96 cM. Genomic screening of 45 genes in this interval including several likely candidate genes (CALB2, CYB5B, TK2, DHODH, PLEKHG4) revealed no mutation. Moreover, we excluded the presence of CNVs using array-based comparative genome hybridization. The identification of a new OPA locus (OPA8) in this pedigree demonstrates further genetic heterogeneity in DOA, and our results indicate that the pathogenesis may still involve mitochondria.",
author = "Valerio Carelli and Simone Schimpf and Nico Fuhrmann and Valentino, {Maria Lucia} and Claudia Zanna and Luisa Iommarini and Monika Papke and Simone Schaich and Sabine Tippmann and Britta Baumann and Piero Barboni and Lora Longanesi and Michela Rugolo and Anna Ghelli and Alavi, {Marcel V.} and Youle, {Richard J.} and Laura Bucchi and Rosanna Carroccia and Giannoccaro, {Maria Pia} and Caterina Tonon and Raffaele Lodi and Giovanna Cenacchi and Pasquale Montagna and Rocco Liguori and Bernd Wissinger",
year = "2011",
month = "5",
doi = "10.1093/hmg/ddr071",
language = "English",
volume = "20",
pages = "1893--1905",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - A clinically complex form of dominant optic atrophy (OPA8) maps on chromosome 16

AU - Carelli, Valerio

AU - Schimpf, Simone

AU - Fuhrmann, Nico

AU - Valentino, Maria Lucia

AU - Zanna, Claudia

AU - Iommarini, Luisa

AU - Papke, Monika

AU - Schaich, Simone

AU - Tippmann, Sabine

AU - Baumann, Britta

AU - Barboni, Piero

AU - Longanesi, Lora

AU - Rugolo, Michela

AU - Ghelli, Anna

AU - Alavi, Marcel V.

AU - Youle, Richard J.

AU - Bucchi, Laura

AU - Carroccia, Rosanna

AU - Giannoccaro, Maria Pia

AU - Tonon, Caterina

AU - Lodi, Raffaele

AU - Cenacchi, Giovanna

AU - Montagna, Pasquale

AU - Liguori, Rocco

AU - Wissinger, Bernd

PY - 2011/5

Y1 - 2011/5

N2 - Dominant optic atrophy (DOA) is genetically heterogeneous and pathogenic mutations have been identified in the OPA1 and OPA3 genes, both encoding for mitochondrial proteins. We characterized clinical and laboratory features in a large OPA1-negative family with complicated DOA. Search for mitochondrial dysfunction was performed by studying muscle biopsies, fibroblasts, platelets and magnetic resonance (MR) spectroscopy. Genetic investigations included mitochondrial DNA (mtDNA) analysis, linkage analysis, copy number variation (CNV) analysis and candidate gene screening. Optic neuropathy was undistinguishable from that in OPA1-DOA and frequently associated with late-onset sensorineural hearing loss, increases of central conduction times at somato-sensory evoked potentials and various cardiac abnormalities. Serum lactic acid after exercise, platelet respiratory complex activities, adenosine triphosphate (ATP) content in fibroblasts and muscle phosphorus MR spectroscopy all failed to reveal a mitochondrial dysfunction. However, muscle biopsies and their mtDNA analysis showed increased mitochondrial biogenesis. Furthermore, patient's fibroblasts grown in the galactose medium were unable to increase ATP content compared with controls, and exhibited abnormally high rate of fusion activity. Genome-wide linkage revealed a locus on chromosome 16q21-q22 with a maximum two-point LOD score of 8.84 for the marker D16S752 and a non-recombinant interval of ~6.96 cM. Genomic screening of 45 genes in this interval including several likely candidate genes (CALB2, CYB5B, TK2, DHODH, PLEKHG4) revealed no mutation. Moreover, we excluded the presence of CNVs using array-based comparative genome hybridization. The identification of a new OPA locus (OPA8) in this pedigree demonstrates further genetic heterogeneity in DOA, and our results indicate that the pathogenesis may still involve mitochondria.

AB - Dominant optic atrophy (DOA) is genetically heterogeneous and pathogenic mutations have been identified in the OPA1 and OPA3 genes, both encoding for mitochondrial proteins. We characterized clinical and laboratory features in a large OPA1-negative family with complicated DOA. Search for mitochondrial dysfunction was performed by studying muscle biopsies, fibroblasts, platelets and magnetic resonance (MR) spectroscopy. Genetic investigations included mitochondrial DNA (mtDNA) analysis, linkage analysis, copy number variation (CNV) analysis and candidate gene screening. Optic neuropathy was undistinguishable from that in OPA1-DOA and frequently associated with late-onset sensorineural hearing loss, increases of central conduction times at somato-sensory evoked potentials and various cardiac abnormalities. Serum lactic acid after exercise, platelet respiratory complex activities, adenosine triphosphate (ATP) content in fibroblasts and muscle phosphorus MR spectroscopy all failed to reveal a mitochondrial dysfunction. However, muscle biopsies and their mtDNA analysis showed increased mitochondrial biogenesis. Furthermore, patient's fibroblasts grown in the galactose medium were unable to increase ATP content compared with controls, and exhibited abnormally high rate of fusion activity. Genome-wide linkage revealed a locus on chromosome 16q21-q22 with a maximum two-point LOD score of 8.84 for the marker D16S752 and a non-recombinant interval of ~6.96 cM. Genomic screening of 45 genes in this interval including several likely candidate genes (CALB2, CYB5B, TK2, DHODH, PLEKHG4) revealed no mutation. Moreover, we excluded the presence of CNVs using array-based comparative genome hybridization. The identification of a new OPA locus (OPA8) in this pedigree demonstrates further genetic heterogeneity in DOA, and our results indicate that the pathogenesis may still involve mitochondria.

UR - http://www.scopus.com/inward/record.url?scp=79955368211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955368211&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddr071

DO - 10.1093/hmg/ddr071

M3 - Article

C2 - 21349918

AN - SCOPUS:79955368211

VL - 20

SP - 1893

EP - 1905

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 10

M1 - ddr071

ER -